Skip to main content

MoneyWorks4Me

Molbio Diagnostics informs about disclosure

13 Oct 2026 Evaluate
Molbio Diagnostics has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund. 

The above information is a part of company’s filings submitted to BSE. 

Peers